Scientists in the US say they have developed an mRNA-based vaccine that encompasses all 20 known subtypes of influenza that could form the basis of a future universal jab. While the shot is still in preclinical development, if it works in human trials it
-based Flu Vaccines Pfizer, BioNTech to Develop mRNA-based Flu VaccinesPfizer, BioNTech to Develop mRNA-based Flu Vaccines
mRNA-based vaccines have the potential to allow rapid manufacture of high-potency products. Credit: BioNTech AG. German biopharmaceutical company BioNTech has signed a research and development (R&D) agreement with Pfizer for the development of mRNA-based vaccines to prevent influenza. Under the multi-...
[05:38.48]However, mRNA vaccines can be produced more quickly. [05:44.07]On July 2, the U.S. government gave $176 million to drug-maker Moderna to finish development and testing of their mRNA vaccine against H5N1. [06:04.00]...
VACCINES mRNA shows promise for a universal flu vaccine A universal flu vaccine that would protect people against new or unfamiliar flu strains has long been a goal of researchers and pharma companies.Results from a new study suggest that the messenger RNA(mRNA)vaccine platform used to make s....
Exceptions were themRNA vaccinescreated for COVID, although even Pfizer and Moderna have had to destroy hundreds of millions of doses of unwanted vaccine as public interest waned. Pfizer and Moderna are testing seasonal influenza vaccinesmade with mRNA, and the government is soliciting bids for mRN...
For the mRNA vaccines, we don’t have the protein.” Because mRNA vaccines instruct your body to make proteins that trigger immune responses rather than rely on weakened or inactivated viruses, they can be developed and updated more quickly. HHS said its award to Moderna was, ...
Data From 5 Studies Show Benefit of Cell-Based Influenza Vaccines Ashley Gallagher, Editor October 24th 2024 Benefits include reducing serious health consequences, such as hospitalization and death, as well as the economic burden on health systems due to influenza infection. ...
Myocarditis: Rare cases of myocarditis, an inflammation of the heart muscle, have been reported among those who have had mRNA COVID-19 vaccines, particularly young males following a second vaccine dose. The connection between myocarditis and the vaccine has drawn attention onsocial mediaand in news...
On that basis, the effectiveness of the vaccines could be increased to as much as 95 percent, the researcher said. So the race is on to develop RNA-based flu vaccines. Norbert Pardi, a vaccine specialist at the University of Pennsylvania, has used mRNA to formulate several antigens in a ...